Randomized Controlled Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma: JCOG0110
European clinical trials of gastrectomy showed that splenectomy is an important risk factor
for post-operative morbidity and mortality. Retrospective comparisons suggested that
splenectomy is associated with poor long term survival. However, Japanese studies revealed
that 20 - 30 % of patients with non-early carcinoma in the proximal stomach have nodal
metastasis in the splenic hilum and therefore, pancreas-preserving splenectomy is part of
the standard operation in specialized centers where splenectomy is not considered a risk
factor for operative mortality. There have been no prospective randomized trials to evaluate
the survival benefit of splenectomy in total gastrectomy for proximal gastric cancer.
Comparison: Total gastrectomy with pancreas-preserving splenectomy versus total gastrectomy
without splenectomy
Interventional
Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Overall survival
During the study conduct
No
Mitsuru Sasako, MD, PhD
Study Chair
Hyogo College of Medicine
Japan: Ministry of Health, Labor and Welfare
JCOG 0110
NCT00112099
June 2002
March 2014
Name | Location |
---|